Trained at the University of Cincinnati, Dr. Cornicelli completed post-doctoral fellowships at the Mayo Clinic Foundation, and Columbia University, where he also held an appointment on the research faculty in the Department of Medicine. He joined Warner-Lambert in 1985 where he became a Research Fellow in the inflammation and cardiovascular therapeutic areas.
During his tenure with Warner-Lambert, and later Pfizer, Dr. Cornicelli served on the atorvastatin discovery and troglitazone development teams. Both of these entities became marketed products. He chaired several discovery teams in the areas of atherosclerosis, inflammation and inflammatory pain.
In 2007, Dr. Cornicelli joined Charles River as the Director of Inflammation and Cardiovascular Pharmacology Services. He is responsible for the portfolio of discovery research services in the areas of inflammation, and metabolic and cardiovascular diseases. He is the author of over 30 publications and 4 patents, and serves as a reviewer for several scientific journals.
Dr. Cornicelli is a Fellow of the American Heart Association’s Council on Atherosclerosis, Thrombosis and Vascular Biology, and a member of the American Physiological Society. In his spare time, Dr. Cornicelli enjoys sports, reading and is an avid amateur photographer.
Joe hasn't added any friends yet.
Click here to see Joe's entire friendlist
